LifeVantage

LFVN

Market cap $109M

Investors need to pay close attention to LFVN stock based on the movements in the options market lately.

LifeVantage Corporation (LFVN) Q3 2026 Earnings Call Transcript

Lifevantage (LFVN) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.26 per share a year ago.

SALT LAKE CITY, May 06, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.050 per share of common stock, which will be paid June 15, 2026 to all stockholders of record at the close of business on June 1, 2026. About LifeVantage Corporation LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within.

SALT LAKE CITY, May 06, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2026. Third Quarter Fiscal 2026 Summary*: Revenue was $43.7 million, a decrease of 25.2% from the prior year period; Revenue in the Americas decreased 28.9%, and revenue in Asia/Pacific & Europe decreased 7.7%; Net income per diluted share was $0.11, versus $0.26 per diluted share a year ago; Adjusted earnings per diluted share was $0.12, compared to $0.26 a year ago; and Adjusted EBITDA was $3.2 million compared to $6.4 million a year ago.

Lifevantage (LFVN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

SALT LAKE CITY, April 22, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its third quarter ended March 31, 2026, after the stock market closes on Wednesday, May 6, 2026. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

SALT LAKE CITY, April 21, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced it has been granted a United States Patent No. 12,589,067 B2, issued March 31, 2026, for nutritional supplement composition and methods for activating cellular signaling genes of its Healthy Glow Essentials Stack™ which contains key activators Protandim® Nrf2 Synergizer® and TrueScience®Liquid Collagen.

SALT LAKE CITY, April 20, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, successfully concluded its three-day Momentum Academy event at Planet Hollywood Resort and Casino in Las Vegas, Nevada. Centered on the theme of “Breakthrough,” the event brought together LifeVantage independent Consultants from across the country for an immersive experience focused on education, connection, and business growth.

SALT LAKE CITY, April 16, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Terrence Moorehead as the Company's new President and Chief Executive Officer and as a member of the Board of Directors (the “Board”), effective August 5, 2026. Mr. Moorehead is expected to commence employment with LifeVantage following the completion of his contractual commitments with his prior employer.